Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

Presentation ESC 2024

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Presenter: Hélène Eltchaninoff

August 31, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation ESC 2018

Durability of Transcatheter Heart Valves - Worse, Similar, or Better than Surgical Valves?

Presenter: Davide Capodanno

August 27, 2018

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

Presentation ESC 2014

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Presenter: Biner S. Finkelstein

September 03, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

Presentation ESC 2012

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Presenter: Markus Ferrari

August 28, 2012

Presentation ESC 2012

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Presenter: 168042|Holger Thiele

August 27, 2012

Advertisement

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Continuation versus Interruption of Oral Anticoagulation during TAVI

Durability of Transcatheter Heart Valves - Worse, Similar, or Better than Surgical Valves?

Guidelines for the Management of Valvular Heart Disease

The Viborg Vascular (VIVA) Randomised Screening Trial

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content